Search results
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
The Motley Fool via AOL· 5 days agoVaccine maker Novavax (NASDAQ: NVAX) isn't dead in the water after all. Though the past 18 months have been tough -- and management warned investors that the business might ...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 4 days agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
Could Novavax Become the Next Moderna? | The Motley Fool
The Motley Fool· 7 days agoNovavax (NVAX -9.65%) and Moderna (MRNA 0.17%) both entered the coronavirus vaccine race around the...
Could Novavax Become the Next Moderna?
The Motley Fool via AOL· 7 days agoNovavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 4 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...
COVID’s New ‘FLiRT’ Variants—What To Know As Experts Fear Summer Surge
Forbes· 2 days agoNew coronavirus variants dubbed “FLiRT” are circulating the world and growing dominant in the U.S.,...
JP Morgan Upgrades Novavax, Inc. (NVAX) to a Neutral from an Underweight – Knox Daily
Knox Daily· 4 days agoNovavax, Inc.’s recently made public that its President, R&D Dubovsky Filip unloaded Company’s shares for reported $0.66 million on May 14 ’24. In the deal valued at $13.90 ...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters via Yahoo Finance· 4 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Shah Capital ends campaign against Novavax board after Sanofi deal By Reuters
Investing.com· 4 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 4 days agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...